You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

HBeAg Negative

Showing 1 - 25 of 9,211
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Chronic Hepatitis B Trial in Guangzhou (NrtIs, HH-003, HH-003+NrtIs)

Active, not recruiting
  • Chronic Hepatitis B
  • Guangzhou, Guangdong, China
    Nanfang Hospital, Southern Medical University
Apr 20, 2023

HBeAg-negative CHB Patients With Indeterminate Phase

Recruiting
  • Chronic Hepatitis b
  • Observation
  • Antiviral treatment
  • Changzhou, Jiangsu, China
  • +4 more
Dec 21, 2022

Chronic Hepatitis B Trial (PEG IFN a-2b; TAF)

Not yet recruiting
  • Chronic Hepatitis B
  • PEG IFN α-2b; TAF
  • (no location specified)
Aug 5, 2022

HBe Negative Chronic Hepatitis B, Hepatitis B Viral Infection Trial in Marseille (CLEVUDINE + TENOFOVIR PLACEBO, CLEVUDINE IN

Terminated
  • HBe Negative Chronic Hepatitis B
  • Hepatitis B Viral Infection
  • CLEVUDINE + TENOFOVIR PLACEBO
  • +2 more
  • Marseille, France
    Hôpital Saint Joseph
Jan 30, 2023

Chronic Hepatitis B Virus Infection Trial in Kaohsiung, Taichung, Taipei (Ropeginterferon alfa-2b, Entecavir)

Recruiting
  • Chronic Hepatitis B Virus Infection
  • Kaohsiung, Taiwan
  • +4 more
Aug 12, 2022

Hepatitis B, Chronic Trial in Worldwide (JNJ-73763989, JNJ-64300535, ETV monohydrate)

Active, not recruiting
  • Hepatitis B, Chronic
  • Edegem, Belgium
  • +12 more
Jan 17, 2023

Chronic Hepatitis B Trial in Zhengzhou (PegIFN a- 2b)

Completed
  • Chronic Hepatitis B
  • PegIFN α- 2b
  • Zhengzhou, Henan, China
    Henan Provincial People's Hospital
Jul 11, 2022

CHRONIC HEPATITIS B Trial in Hô` Chi´ Minh (CTH Chronic Hepatitis B)

Approved for marketing
  • CHRONIC HEPATITIS B
  • CTH Chronic Hepatitis B
  • Hồ Chí Minh, Ho Chi Minh City, Vietnam
    Saigon Biopharma Company Limited
Oct 6, 2021

Chronic Hepatitis B Trial (Bepirovirsen, Placebo)

Recruiting
  • Chronic Hepatitis B
  • Herston, Queensland, Australia
  • +7 more
Jan 23, 2023

Hepatitis B, Chronic Trial in Worldwide (IMC-I109V-101 Single Ascending Dose, IMC-I109V-101 Multiple Ascending Doses)

Recruiting
  • Hepatitis B, Chronic
  • IMC-I109V-101 Single Ascending Dose
  • IMC-I109V-101 Multiple Ascending Doses
  • Los Angeles, California
  • +19 more
May 10, 2023

Chronic Hepatitis B Trial in Worldwide (Bepirovirsen, Placebo)

Recruiting
  • Chronic Hepatitis B
  • Victoria, British Columbia, Canada
  • +10 more
Jan 23, 2023

Chronic Hepatitis B Trial in Singapore (Placebo Oral Tablet, Nitazoxanide)

Active, not recruiting
  • Chronic Hepatitis B
  • Singapore, Singapore
    National University Hospital
Feb 5, 2021

Chronic Hepatitis B Trial in Amsterdam (Peg-Interferon alfa 2a + Adefovir dipivoxil, Peg-Interferon alfa 2a + Tenofovir

Completed
  • Chronic Hepatitis B
  • Peg-Interferon alfa 2a + Adefovir dipivoxil, Peg-Interferon alfa 2a + Tenofovir disoproxil fumarate
  • Amsterdam, Noord-Holland, Netherlands
    Academic Medical Center
Mar 25, 2021

Hepatitis B, Chronic Trial in Worldwide (Stop of therapy)

Active, not recruiting
  • Hepatitis B, Chronic
  • Stop of therapy
  • København, Denmark
  • +10 more
Sep 13, 2021

Chronic Hepatitis B Virus Trial in San Francisco (Stop NA therapy)

Active, not recruiting
  • Chronic Hepatitis B Virus
  • Stop NA therapy
  • San Francisco, California
  • +1 more
Mar 29, 2021

Hepatitis B Trial in New Delhi (Peg IFN 2b)

Unknown status
  • Hepatitis B
  • Peg IFN 2b
  • New Delhi, Delhi, India
    Institute of Liver and Biliary Sciences
Feb 1, 2020

Chronic Hepatitis B (HBeAg-negative) Trial (Pegylated interferon alfa-2a)

Completed
  • Chronic Hepatitis B (HBeAg-negative)
  • Pegylated interferon alfa-2a
  • (no location specified)
Sep 4, 2019

CHRONIC HEPATITIS B Trial in Tehran (LAMIVUDINE)

Completed
  • CHRONIC HEPATITIS B
  • Tehran, Iran, Islamic Republic of
    GSK Clinical Trials Call Center
Feb 28, 2020

Hepatitis B, Chronic Trial in Changchun (drug, other, combination product)

Not yet recruiting
  • Hepatitis B, Chronic
  • Changchun, Jilin, China
    The First Hospital of Jilin University
Jul 29, 2022

Chronic Hepatitis B Trial in Canada, Netherlands (Peginterferon alfa-2a, Nucleos(t)ide analogue)

Completed
  • Chronic Hepatitis B
  • Peginterferon alfa-2a
  • Nucleos(t)ide analogue
  • Toronto, Ontario, Canada
  • +7 more
Nov 7, 2019

Hepatitis B, Chronic Trial in Worldwide (administration of SLGN in arm C, Discontinuation of NUC treatment in arms B and C)

Recruiting
  • Hepatitis B, Chronic
  • administration of SLGN in arm C
  • Discontinuation of NUC treatment in arms B and C
  • Lyon, France
  • +7 more
Mar 11, 2022

Chronic Hepatitis B Trial in Zhengzhou (continuous treatment, pulse therapy)

Recruiting
  • Chronic Hepatitis B
  • continuous treatment
  • pulse therapy
  • Zhengzhou, Henan, China
    Henan Provincial People's Hospital
Jul 13, 2022

Chronic HBV Infection Trial in Shenzhen (Peginterferon alfa-2b combined and ETV)

Recruiting
  • Chronic HBV Infection
  • Peginterferon alfa-2b combined and ETV
  • Shenzhen, China
    Shenzhen Third People Hospital
Mar 19, 2023

After Long-Term Antiviral Treatment for Chronic Hepatitis B

Completed
  • Chronic Hepatitis B e Antigen Positive
  • Chronic Hepatitis B e Antigen Negative
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 26, 2023

    Chronic Hepatitis B, Non-alcoholic Fatty Liver Disease Trial in Taipei (exercise)

    Enrolling by invitation
    • Chronic Hepatitis B
    • Non-alcoholic Fatty Liver Disease
    • exercise
    • Taipei, Zhongzheng Dist., Taiwan
      National Taiwan University Hospital
    Jul 13, 2023